Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Mar 2020 for Bellicum Pharmaceuticals, INC, €18k.
Filing timeline
BuySaleRichard A. Fair
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Richard A. Fair: trading record in brief
Richard A. Fair discloses dealings in Bellicum Pharmaceuticals, Inc to SEC (Form 4). Between 21 August 2019 and 17 March 2020, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (3 purchases, €81k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2020 to date brings 1 purchase and no sales.
The median purchase comes to €18k. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 19 March 2020 with an open-market purchase (€18k) in Bellicum Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard A. Fair
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
5,000 shares@ US$4.00100.0% of flowCommon StockSEC:0001628280-20-003793:0
Canonical exit: 15 Jun 2020 (T+90)
40,000 shares@ US$1.2555.9% of flowCommon StockSEC:0001209191-19-049227:0
Canonical exit: 9 Dec 2019 (T+90)
20,000 shares@ US$0.98922.0% of flowCommon StockSEC:0001358403-19-000111:0
Canonical exit: 19 Nov 2019 (T+90)
3 of 3 declarations
